Guardian Pharmacy Services (NYSE:GRDN) Stock Price Expected to Rise, Truist Financial Analyst Says

Guardian Pharmacy Services (NYSE:GRDN) had its price objective lifted by research analysts at Truist Financial from $47.00 to $51.00 in a report released on Monday, MarketBeat.com reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 14.43% from the company’s previous close.

Several other brokerages have also issued reports on GRDN. Oppenheimer raised their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 20th. Bank of America raised their price objective on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Finally, Wall Street Zen lowered shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Saturday. Nine equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $45.57.

Guardian Pharmacy Services Stock Up 0.9%

Shares of NYSE GRDN opened at $44.57 on Monday. The company has a market capitalization of $2.22 billion, a PE ratio of 43.27, a PEG ratio of 2.29 and a beta of 0.06. The stock’s 50 day moving average price is $40.66 and its 200-day moving average price is $39.06. Guardian Pharmacy Services has a twelve month low of $23.14 and a twelve month high of $48.33.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The company had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. As a group, research analysts expect that Guardian Pharmacy Services will post 1.19 EPS for the current fiscal year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several large investors have recently added to or reduced their stakes in the company. Arizona State Retirement System raised its stake in shares of Guardian Pharmacy Services by 53.0% during the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after purchasing an additional 2,907 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Guardian Pharmacy Services during the 2nd quarter worth about $335,000. Round Rock Advisors LLC boosted its stake in Guardian Pharmacy Services by 57.0% in the 2nd quarter. Round Rock Advisors LLC now owns 18,524 shares of the company’s stock worth $776,000 after purchasing an additional 6,729 shares during the period. Braun Stacey Associates Inc. bought a new position in Guardian Pharmacy Services in the 2nd quarter worth about $14,234,000. Finally, Ranger Investment Management L.P. purchased a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $7,263,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.